ABSTRACT Normal hearing in mammals depends on sound amplification by outer hair cells (OHCs) presumably by their somatic motility and force production. However, the role of OHC force production in cochlear amplification and frequency tuning are not yet fully understood. Currently, available OHC manipulation techniques for physiological or clinical studies are limited by their invasive nature, lack of precision, and poor temporal-spatial resolution. To overcome these limitations, we explored an optogenetic approach based on channelrhodopsin 2 (ChR-2), a direct light-activated nonselective cation channel originally discovered in Chlamydomonas reinhardtii. Three approaches were compared: 1) adeno-associated virus-mediated in utero transfer of the ChR-2 gene into the developing murine otocyst, 2) expression of ChR-2(H134R) in an auditory cell line (HEI-OC1), and 3) expression of ChR-2 in the OHCs of a mouse line carrying a ChR-2 conditional allele. Whole cell recording showed that blue light (470 nm) elicited the typical nonselective cation current of ChR-2 with reversal potential around zero in both mouse OHCs and HEI-OC1 cells and generated depolarization in both cell types. In addition, pulsed light stimulation (10 Hz) elicited a 1:1 repetitive depolarization and ChR-2 currents in mouse OHCs and HEI-OC1 cells, respectively. The time constant of depolarization in OHCs, 1.45 ms, is 10 times faster than HEI-OC1 cells, which allowed light stimulation up to rates of 10/s to elicit corresponding membrane potential changes. Our study demonstrates that ChR-2 can successfully be expressed in mouse OHCs and HEI-OC1 cells and that these present a typical light-sensitive current and depolarization. However, the amount of ChR-2 current induced in our in vivo experiments was insufficient to result in measurable cochlear effects.
INTRODUCTION
Normal hearing in mammals depends on both soundcaused vibration detection by inner hair cells (IHCs) and vibration amplification by outer hair cells (OHCs). The membrane voltage-dependent somatic motility of OHCs is a major component of the cochlear amplification process (1) (2) (3) (4) (5) using the motor molecule, prestin (6) . The active experimental control of OHC motility would enable study of a number of basic physiological problems such as the origin of reverse traveling waves, power generation by the OHCs, and the time constant limitation of OHC motility. In addition, functional control of OHCs could have a clinical purpose in a manner analogous to the function of cochlear implants.
To control OHC membrane potential, we used an optogenetic approach based on channelrhodopsin 2 (ChR-2), a direct light-activated nonselective cation channel (NSCC) originally from Chlamydomonas reinhardtii (7). When exposed to light, ChRs open and depolarize the cell. Since the first characterization of ChR1 (8) and ChR-2 (7), ChRs have been functionally expressed in cultured cells and native neurons in living animals and have been used as optogenetics tools in many in vitro and in vivo biological studies (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . ChR-2 was the first developed ChR used to excite neurons due to adequate expression in mammalian systems. When ChR-2 was expressed in neurons, pulsed blue light produced neuronal spikes in a millisecond scale (20) (21) (22) . To the best of our knowledge, an optogenetic approach has not been reported for any type of sensory cell.
In the current study, an in utero gene transfer method was used to express functional ChR-2 in outer hair cells (23) . We also expressed ChR-2(H134R), a gain-of-function point mutant (22) , in the auditory cell line (HEI-OC1), which expresses prestin, the OHC-specific transmembrane motor protein. With whole cell recording, we found that blue light (470 nm) activated the typical NSCC current of ChR-2 in both mouse cochlear OHCs and HEI-OC1 cells and generated significant depolarization in both cell types. We also developed a conditional genetic model targeting ChR-2(H134R) to prestin-expressing OHCs. The expression of ChR-2(H134R) was largely, but not exclusively, confined to OHCs. Light stimulation of the cochlea of anesthetized mice alone or in conjunction with simultaneous sound stimulation, however, did not yield detectable changes in cochlear sensitivity as assessed by electrophysiological and micromechanical methods.
MATERIALS AND METHODS

Ethical approval
All procedures in this study were approved by the Institutional Animal Care and Use Committee of Oregon Health and Science University.
In utero ChR-2-tdTomato viral transduction of otic precursors that give rise to OHCs
The animal model used was a cross between CBA/CaJ mice (The Jackson Laboratory, Bar Harbor, ME) and the prestin-CreER T2 knockin mouse line, kindly provided by Dr. Jian Zuo (St. Jude Children's Hospital) (24) . The CreER T2 fusion protein is expressed only in OHCs and translocates into the nucleus upon tamoxifen binding. To produce OHC-specific ChR-2 expression, the adeno-associated viral vector, AAV2/1.CAGGS.flex.ChR-2.tdTomato.SV40, was microinjected through the uterus into the otic vesicle at embryonic day 12.5. The detailed methodology has been previously described (23, 25) . The adeno-associated viral vector was obtained from the University of Pennsylvania Vector Core. The original plasmid was provided by Scott Sternson (Addgene plasmid 18917) (26) . The virally encoded flip-excision or FLEX construct allows for expression of ChR-2 as a fusion protein with the fluorescent marker tdTomato in a Cre recombinase-dependent manner (26) . Intraperitoneal injection of tamoxifen (0.075 mg/g body weight) was performed on P3 and P4 to induce the expression of ChR-2-tdTomato ( Fig. 1) .
Generation of OHC-specific ChR-2(H134R)-tdTomato expressing mice
Heterozygous Ai27D (B6.Cg-Gt(ROSA)26Sor tm27.1(CAG-COP4 * H134R/tdTomato)Hze / J mice (27) (The Jackson Laboratory), which bear a conditional allele encoding the ChR-2(H134R)-tdTomato fusion protein on a C57BL/6J background were crossed with the prestin-CreER T2 knockin mouse line described previously. Offspring carrying the ChR-2(H134R)-tdTomato allele were identified by genotyping as recommended (The Jackson Laboratory). Tamoxifen treatment at P7 and P8 enabled Cre-mediated removal of a loxP-flanked STOP cassette upstream of the ChR-2(H134R)-tdTomato gene, and OHC-specific ChR-2(H134R)-tdTomato was observed. We noted that the Ai27D adult mice were smaller in size and weight than wild-type C57BL/6J counterparts. Additionally, all offspring, regardless of whether or not the transgene was present, were also smaller in size and weight relative to age-matched C57BL/6J mice.
HEI-OC1 cell culture and ChR-2(H134R)-mCherry expression
The auditory cell line, HEI-OC1, was kindly provided by Dr. Federico Kalinec (University of California, Los Angeles) (28) . The cells were cultured in high glucose Dulbecco's modified Eagle medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum and 10 mg/L of g-interferon at 33 C in a humidified 10% CO 2 incubator. 24 h after plating onto 35 mm glass bottom dishes (MatTek, Ashland, MA), the cells were transfected with pcDNA3.1/hChR-2(H134R)-mCherry (provided by Dr. Karl Deisseroth (Addgene plasmid 20938)) (29) using TransIT-TKO (Mirus Bio, Madison, WI) according to the manufacturer's instructions. The cells were then cultured for an additional 24 h with 1.0 mM all-trans retinal (Sigma-Aldrich, St. Louis, MO) before patch clamp recordings. Transfected cells were identified by visualization of fluorescent ChR-2(H134R)-mCherry expression (Fig. 2) .
Patch clamp
OHC preparation for in vitro recording
Mice (P10-12) were anesthetized by intramuscular injection of 30 mg/ml ketamine and 5 mg/ml xylazine in saline and killed by decapitation. The cochleae were rapidly removed from the temporal bone and dissected in a standard artificial perilymph composed of (mM): NaCl 144, KCl 4, CaCl 2 1.3, MgCl 2 0.9, Na 2 HPO 4 0.7, HEPES 10, and glucose 5.6. The osmolarity of the solution was adjusted to 304 mOsm/l with glucose and the pH was adjusted to 7.4 with NaOH. All procedures were performed at room temperature (22 C) . The organ of Corti dissected from the apical and second turn was digested with dispase I (1.0 mg/ml) for 12 min at 22 C. Dissociated OHCs, obtained by gentle titration, were placed in a petri dish and allowed to settle onto the glass bottom (see a more detailed description in (30)). ChR-2 expressing OHCs were identified for patch clamp recording by visualization of tdTomato fluorescence. The OHCs lengths ranged from 15 to 25 mm.
Light stimulation in vitro
The light source for the in vitro study was a blue (470 nm) collimated LED from Thorlabs (Newton, NJ), which was delivered by an optic fiber with 1 mm diameter. The optical fiber was positioned at a distance of 300 mm from the OHCs or HEI-OC1 cells. The calibrated blue light power delivered to cells was 0.52 mW/mm 2 . The light pulses with specific durations and intervals were triggered by a voltage pulse generator (Master-8, AMPI, Jerusalem, Israel). FIGURE 1 Creation of OHC-specific expression of ChR-2-tdTomato. The adeno-associated viral vector (AAV2/1.CAGGS.flex.ChR-2.tdTomato. SV40) with ChR-2-tdTomato was injected through the uterus into the otic vesicle of E12.5 embryos heterozygous for prestin-CreER . Tamoxifen (intraperitoneal injection at 0.075 mg/g per day for 2 consecutive days) was performed at P3 and P4 to induce the OHC-specific expression of ChR-2, which was shown in the representative confocal images of whole mount (5 weeks old mice cochlear basal turn) in (A) and vibratome sections (7 weeks old mice cochlear basal turn) in (B). Differential interference contrast. Scale bar, 40 mm. 
Solutions
All reagents were from Sigma-Aldrich. The drugs were gravity delivered at a rate of 0.35 ml/min, through an array of parallel polyethylene tubes with an inner diameter of~280 mm at the distal end. Bath solutions (mM) were 1) Na 
Whole cell recordings
A brief description is as follows. Detailed methodologies are given in our previous works (30, 31) . For current detection, an Axopatch one-dimensional amplifier (Axon Instruments, Union City, CA) was used with its low-pass filter set to 1 kHz. Membrane currents were recorded for episodic I-V commands with a Digidata 1322A interface and pCLAMP 8 software (Molecular Devices, Sunnyvale, CA) at a sampling rate of 10 kHz. A simultaneous continuous gap-free recording was conducted with Minidigi digitizer and Axoscope 9.2 software (Axon Instruments) at a sampling rate of 50 Hz. Through the gap-free recording, we continuously monitored the holding current at specific holding potentials (Vhold) and its changes by light pulse stimuli. The whole cell configuration was achieved by rupturing the cell membrane with suction after achieving a high resistance seal (>1.5 gigohm). Stability and quality of the patch was ascertained by monitoring the gap-free recording and the cell parameters (cell capacitance (C cell ), membrane resistance (R m ), and series resistance (R s )) during the recordings. The patch pipettes were pulled with a puller (P80/PC Sutter Instruments, Novato, CA) in four steps from the borosilicate capillaries (1B150F-4, WPI, Sarasota, FL), having an initial resistance of 4-5 megaohm in our regular Na þ rich bath and with K þ -rich pipette solutions. The 
In vivo methods
Light stimulation in vivo
The light source used for in vivo experiments was a blue (465 nm) LED source from Plexon, (Dallas, TX) coupled with an optic fiber of diameter 200 mm. The maximum power output of the source was 20 mW at the fiber tip giving intensity of 637 mW/mm 2 . The tip was positioned very near, but not contacting, the round window. The light intensity at the OHCs in basal turn within the cochlea would be lower than 637 mW/mm 2 exiting the fiber tip due to conical spreading of light after exiting the light-fiber, as well as from scattering and absorption in the tissue (32) . We visualized the decrease in light intensity with distance from the fiber tip in an in vitro preparation consisting of the mouse cochlea immersed in artificial perilymph solution mixed with 30 mM fluorescein (Fluorescein sodium salt F6377 from Sigma-Aldrich (St. Louis, MO)); for method, see Campagnola et al. (33) ) and compared it with the light intensity without the cochlea present. The additional drop in light intensity in passing through the round window appeared to be very small. To estimate light intensity at the organ of Corti in the hook region of the mouse cochlea, we used the analysis in Zhang et al. (34) . A conservative estimate leads to 20 times reduction in intensity at the organ of Corti in the basal turn and hook region, giving the estimated intensity to be 32 mW/mm 2 , and a further loss of light intensity due to organ of Corti tissue was estimated by a factor of~0.2 based on the method described in Aravanis et al. (32) . This gives an intensity of at least 6 mW/mm 2 , which is above the value 5 mW/mm 2 for in vivo ChR-2 excitation recommended in Zhang et al. (34) and the 0.51 mW/mm 2 we found to be sufficient for excitation of isolated OHCs.
CM and quadratic distortion frequency following response
The animals were anesthetized with xylazine (10 mg/kg, IVX; Animal Health, Greeley, CO) and ketamine (40 mg/kg, Hospira, Lake Forest, IL). Body temperature was measured by a rectal probe and maintained by a feedback controlled temperature system (Fred Haer, Bowdoin, ME). Head and cochlear temperature were maintained by supplemental heat from a lamp.
To assess that the physiological condition of the cochlea was normal, criterion compound action potential (CAP) thresholds for pure tone-burst stimuli (8-55 kHz) were compared with age-matched littermates without ChR-2. CAP criterion was a 10 mV negative voltage deflection at the round window evoked by a 1 ms rise time tone burst. Experiments were conducted on mice having <10 dB of threshold shift from normal at the frequency of interest.
A 25 mm silver wire electrode was positioned at the edge of the round window to record CM in anesthetized mice. The acoustic stimuli were continuous sounds or tone pips. A silver chloride wire in neck muscle served as the reference electrode. The CM signal was digitalized and multiple presentations were averaged for offline analysis.
The 900 Hz quadratic distortion product CM is mainly an auditory nerve (AN) frequency following response (35) . As an AN response, the 900 Hz quadratic distortion product effectively tracts the cochlear compound action potential (usually evoked by transient acoustic stimuli) sensitivity/threshold as a continuous signal. The synchronizing effect (perhaps on the baseline open channel IHC current) extends to near and below auditory thresholds. Two continuous tones (F1 and F2), separated in frequency by 900 Hz, were presented at equal sound intensity levels and delivered to the external ear of the mouse. To assess basal cochlear (high frequency) responses to blue light, the recording electrode and the light stimulus were at the round window location. The F1 frequencies were 24, 30, 35, and 40 and 49.1 kHz and sound level was varied between 40 and 90 dB SPL. The 900 Hz CM was digitally recorded. 100 light pulses (100 ms duration with 300 ms intervals) were averaged to observe any change in the 900 Hz response.
Statistics
Data are presented as means 5 SE from n observations. Student's t-test (paired or nonpaired as appropriate) was performed using Microsoft Excel software (Seattle, WA); p % 0.05 represents a significant difference.
RESULTS
Visualization of ChR-2 expression in mouse OHCs and HEI-OC1 cells
For in vivo expression of ChR-2 in mouse OHCs, the otic vesicles of day 12.5 embryos were microinjected with AAV2/1 virus and the embryos were carried to term. Following tamoxifen treatment of P3 and P4 pups, ChR-2-tdTomato expression was observed at P7 in >30% of OHCs (data not shown). Patch recording was performed at P10-12 at which point >60% of OHCs had ChR-2 expression. In mature mice (5 to 7 weeks old), ChR-2-tdTomato Biophysical Journal 110(2) 493-502 was still specifically expressed in OHCs with an average of 56 5 7% of OHCs in the mid-region of the cochlea displaying ChR-2-tdTomato expression (Fig. 1) . The expression pattern was anticipated to be incomplete as microinjection of the otic vesicle with AAV2/1 is known to result iñ 60% OHC expression (36) . Additionally, transduction rates were highest in the apical OHCs and lowest in the OHCs located in the basal region of the cochlea (data not shown), consistent with previous observations of auditory hair cell AAV2/1 transduction (37). Here, only an average of 18 5 10% of OHCs in the hook region had ChR-2-tdTomato expression (data not shown). Due to the inefficient transduction of basal located OHCs, the in utero method proved unsuitable for in vivo basal cochlear mechanics studies. However, for in vitro analysis of ChR-2 activity, apical turn OHCs were isolated from organ of Corti explants from these mice. The hChR-2(H134R)-mCherry fusion protein was well expressed in the auditory hair cell line HEI-OC1 (Fig. 2) .
A characteristic ChR-2 current and depolarization in HEI-OC1 cells
In the regular Na þ -rich bath and K þ -rich pipette solutions, 100 ms light pulse (470 nm, 0.52 mW/mm 2 power) elicited typical ChR-2 currents at different holding potentials (Vhold) (Fig. 3, A and C) , in ChR-2 (þ) HEI-OC1 cells; i.e., inward currents at negative Vholds that rapidly rose to a peak and subsequently relaxed to a steady-state level and similar outward currents at positive Vholds (Fig. 3 A) . The average net peak and steady-state currents at Vhold of À80 mV were À38.0 5 11.6 and À23.6 5 5.8 pA/pF (n ¼ 5), respectively. I-V plots showed the reversal potential (Vr) near 0 mV. In the control ChR-2 (À) cells, the same light pulse did not activate any significant current (Fig. 3 , B and D). In the solutions blocking all K conductances (Cs rich extra and intracellular solutions), similar typical ChR-2 currents were elicited as well with Vr near 0 mV and the average net peak current at À60 mV was À15.9 5 2.1 pA/pF (n ¼ 4) (Fig. 4, A and B) .
In I-clamp mode with Na-rich bath solution and K-rich pipette solution, a 100 ms light pulse transiently depolarized ChR-2 (þ) HEI-OC1 by 11.7 mV (from À16.5 5 2.1 to À4.8 5 1.2, n ¼ 7, p < 0.05) (Fig. 5, A and C) . In comparison, no significant change in membrane potential was elicited in ChR-2 (À) cells (from À41.8 5 4.2 to À41.5 5 4.3, n ¼ 4, p > 0.05) (Fig. 5, B and C) . The average resting potential of ChR-2 (þ) HEI-OC1 is more depolarized than ChR-2 (À) cells, which likely resulted from strong ChR-2 expression in HEI-OC1 cells and a small amount of ambient light exposure, although the experiment was performed in an almost completely dark room. Fig. 6 shows that repetitive short-pulsed light stimulation (10, 20 , and 40 Hz with 20 ms duration) elicited repetitive ChR-2 currents at À60 mV of Vhold. The peak currents showed a rundown, which was more prominent and quicker to reach a steady state at higher frequencies in ChR-2 (þ) HEI-OC1 cells, in agreement with an earlier report (38) . As expected, increasing in stimulation frequency decreased the amplitude of zigzag current amplitude. In the tested light frequency range (10-40 Hz), the light pulse train elicited repetitive currents generally arrived at a steady-state level 61% of the initial peak amplitude.
In vivo ChR-2 expression
As previously discussed, the AAV2/1 virally transduced ChR-2 tdTomato mouse model was not suitable for basal turn physiological studies due to the low transduction rate in the lower basal region. Therefore, to obtain a high level of ChR-2 expression in the OHCs of the hook region of the cochlea, we crossed Ai27D (ChR-2(H134R)-tdTomato) mice with prestin-CreER T2 mice. Adult (6 weeks) offspring have normal auditory brainstem responses and distortion product otoacoustic emission levels (data not shown). Fluorescent imaging revealed the presence of tdTomato expression in the OHCs in the hook regions of these mice. However, by 8 weeks of age, tdTomato expression was also present in many other cell types in the cochlea, including IHCs, supporting cells, and the spiral ganglion cells.
A characteristic ChR-2 current and depolarization in mouse cochlear OHCs Consistent with the finding in HEI-OC1 cells, in solutions blocking all K conductance, 100 ms light pulse (470 nm, 0.52 mW/mm 2 ) elicited typical ChR-2 currents (Fig.7 A) in ChR-2 (þ) OHCs; i.e., inward currents at negative Vholds with a rapidly rising peak and subsequent relaxation to a steady-state level (Fig. 7 A) . The average net peak and steady-state currents at Vhold of À80 mV are À10.0 5 2.8 and À3.4 5 1.1 pA/pF (n ¼ 5), respectively. I-V plots showed the reversal potential (Vr) near 0 mV (see Fig. 7 D) . In the control ChR-2 (À) OHCs, the same light pulse did not activate any significant current (Fig. 7, B and D) .
In I-clamp mode, the light pulse transiently depolarized ChR-2 (þ) OHCs by 5.0 mV (from À56.5 5 4.8 to À51.5 5 3.7, n ¼ 3, p < 0.05) (Fig. 8, A and C) . In I-V plots of net ChR-2 peak and steady-state currents in ChR-2 (þ) OHCs (n ¼ 4, 5) and net peak currents in ChR-2 (À) OHCs (n ¼ 5) normalized by cell capacitances (pF) at Vhold ¼ À40 mV. Net peak current; the delta between the peak current and the 50 ms average current before the peak current. Net steady-state current; the delta between the average steady-state current (last 10 ms) and the 50 ms average current before the peak current. To see this figure in color, go online.
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comparison, no significant change in membrane potential was elicited in ChR-2 (À) OHCs (from À46.5 5 2.9 to À46.6 5 3.1, n ¼ 3, p > 0.05) (Fig. 8, B and C). The 10 Hz pulsed-light stimulation (470 nm, 0.52 mW/mm -2 ) with 20 ms duration and 100 ms duty cycle elicited 1:1 repetitive depolarizations with initial rundown in amplitudes (Fig. 8 D) . The membrane depolarization rising and falling phases were fitted with one term exponential function (y ¼ Axe Àx/t þ Y 0 ) with time constant t ¼ 1.45 and regression coefficient of 0.997 for mouse OHCs and with t ¼ 15.76 and regression coefficient of 0.996 for HEI-OC1 cells. Interestingly, unlike HEI-OC1 cells (Fig. 5 C) , ChR-2 expression in the OHCs did not significantly change the resting membrane potential (Fig. 8 C) , which may result from much less expression of ChR-2 in mouse OHCs compared with HEI-OC1 cells.
Assessment of the in vivo model
The activation of OHCs expressing ChR-2 in the intact ear would be expected to depolarize OHCs, as we observed in vitro. Depolarization of activated prestin would result in an electromotile change in the length of the cell applying force to the organ of Corti structures at the two ends of OHCs. ChR-2's characteristic onset time, the desensitizing cation current pattern (Fig. 7) , and the resulting induced voltage (Fig. 8) , are very slow compared to conventional OHC receptor potentials evoked by sound stimulation. However, the dynamics of a light-induced response are not necessarily a problem for designing useful experiments using ChR-2, as even steady-state forces would result in altered physiology.
Lack of effect on the CM
The cochlea of mice with or without ChR-2 expressing OHCs in the basal turn/hook area of the cochlea produced a robust CM potential in response to sounds of appropriate frequency to maximally stimulate the basal turn and hook regions of the cochlea (30 kHz and higher frequencies). We recorded the CM from the round window niche (not blocking access of the light). A tone burst of 400 ms duration was synchronized with a light pulse of 100 ms that occurred within the duration of the tone. This light/tone complex was repeated 100 times at the rate of 1/s and averaged. The resulting CM data was analyzed by the short-time fast Fourier transform (FFT) method. Any light-induced artifact transients were modeled and subtracted before FFT. Our patch clamp experiments on isolated OHC shows that the ChR-2-induced depolarization has an onset time of 1.45 ms that was followed by desensitization. The analyzed bins of the FFT were timed to be at the onset and desensitization phase and the later steady-state phase (75 ms) of the light-induced ChR-2 current. Statistical analysis found no significant change of the CM, although there were light-induced onset and offset artifact voltage transients that were not dependent on ChR-2 expression.
Lack of effect on the quadratic distortion product
Two sounds presented at a low intensity and having a 900 Hz frequency difference can elicit a very strong AN frequency following response (35, 39) . The 900 Hz signal is a result of nonlinear transduction in the organ of Corti. The quadratic distortion AN steady-state response is exquisitely sensitive to cochlear amplification gain. We used two acoustic tones presented at sound levels lower than behavioral auditory thresholds (~15 dB SPL). Any change in system gain, induced by light, will result in a change (a reduction) in the AN response. No significant change was observed for either high-frequency F 1 and F 2 (24 kHz and 25.9 kHz or 49.1 kHz and 50 kHz for round window applied light) or low-frequency primary tones (12 kHz and 12.9 kHz for apically applied light). 
DISCUSSION
Experimental control of OHC function in a noninvasive, cell specific, and precisely localized and timed manner was the goal of the optogenetic approach used in the current study. The opsins have a rich palette of properties such as reversible activation and inhibition of cell function. For OHCs and cochlear physiological experiments, opsins represent an approach that is more fine-tuned than, e.g., light-activated salicylate (40) . However, there has been no report on ChRs application in the cochlea hair cells, although expression in auditory neurons has been accomplished (41) . This report is the first demonstration, to our knowledge, that ChR-2 can be successfully expressed in mouse OHCs and HEI-OC1 cells and can present a typical lightsensitive current and depolarization. The following sections discuss the results of our diverse experiments:
In vivo expression of ChR-2 in mouse OHCs
Using the previously developed in utero gene transfer method (23), we generated mice in which, by P10-12, 56 5 7% of OHCs had potent ChR-2-tdTomato expression with a characteristic ChR-2 current. This data validates a good efficacy of the in utero gene transfer method. So far, it is the only successful and mature method available to transfer specific genes into specific mammalian hair cells. However, in utero gene transfer did not prove efficient for ChR-2-tdTomato expression in OHCs of the lower basal turn and hook areas. An extensive analysis of viral tropism, to include chimeric capsid proteins, as well as novel promoter sequences is warranted to solve the basal cochlear gene expression limitation. The in utero gene transfer method is clearly relevant for gene misexpression studies, for which there are no available transgenic mice and may be useful to future clinical applications aimed at restoring auditory function in congenital deafness.
A critical question about expressing ChR-2-tdTomato in OHCs is whether this caused any detrimental effect on OHC function. We found normal auditory brainstem responses at high frequencies in adult mice expressing ChR-2-tdTomato in OHCs (data not shown) and comparable resting potentials between ChR-2 (þ) OHCs and wildtype OHCs. This suggests that there is no significant detriment to OHC function caused by ChR-2-tdTomato expression.
The in vitro model: a characteristic ChR-2 current and depolarization in HEI-OC1 cells and mouse cochlear OHCs
To test and confirm functional expression of ChR-2 in relevant cells we expressed ChR-2(H134R)-mCherry, a gain of function point mutant of ChR-2. Strong mCherry fluorescence was observed in HEI-OC1 cells with the characteristic currents indicating functional expression of ChR-2(H134R). The average peak current per pF (15.9 pA at À60 mV) in HEI-OC1 cells was three times higher than mouse OHCs (5.2 pA at À60 mV) suggesting more efficient ChR-2 expression in cultured cells. Consistent with the literature (17), the ChR-2(H134R) current had a lower level of desensitization than ChR-2 with steady-state/peak ratio, 0.61 vs. 0.31. In addition, consistent with the finding in mouse OHCs, the pulsed light stimulation (10, 20, 40 Hz) elicited repetitive currents, which stayed at the steady-state level (61% of the initial peak level) despite incomplete recovery. Light at 470 nm with the power density of 0.52 mW/mm 2 elicited a typical ChR-2 current with a rapid rising peak and a subsequent relaxation to a steady-state level (Fig. 7 A) . The I/V plot with Vr around 0 mV is consistent with the NSCC property of ChR-2 (Fig. 7 D) . The level of desensitization of ChR-2 current (steady state/peak) is 0.31 (at a holding potential of À60 mV), slightly higher than the other heterogeneous expression system, 0.22 (17) . The difference may result from different cell types and cell conditions. Consistent with the findings in voltage clamp, the inward ChR-2 current at RP (around À60 mV) caused an average depolarization of 5.0 mV in mouse OHCs. Additionally, pulsed light stimulation (10 Hz) elicited a clear 1:1 repetitive depolarization in mouse OHCs. However, the amplitudes in the second and succeeding depolarization responses were reduced because of the longer time needed to completely recover to its initial level. Nevertheless, the repetitive response level in (isolated) OHCs can be always kept at the steady-state level around one-third of the first depolarization amplitude (1.67 mV). The critical question is then whether this amount of ChR-2 current can control membrane potential to generate a significant change in OHC electromotility in vivo. This is addressed below.
The in vivo model: lack of effect of ChR-2
The search for an in vivo response was fraught with problems. The attempt to generate ChR-2-tdTomato expressing OHCs by the in utero method was extremely inefficient in the lower basal turn and hook region of the cochlea. However, this method provided the source for isolated OHCs for the characterization of light-induced whole cell currents and voltages and provided validation to define another model. Prestin-Cremediated expression of the ChR-2-tdTomato conditional allele in OHCs, although much more efficient, was still subject to expression issues. Here, we found variable expression of ChR-2 in OHCs and significant off-target ChR-2 expression in neurons, IHCs, and supporting cells. Furthermore, due to the C57Bl/6 strain background, OHCs were quickly lost from the hook area, potentially influencing the amount and quality of light-induced physiology effects in hook and lower first cochlear turn.
We verified that sufficient light power was delivered to basal turn OHCs by in vitro calibration experiments with excised mouse cochleas. From our in vitro whole cell current measurements, we found a classical cationic current that at best produced a few millivolts of depolarization Biophysical Journal 110(2) 493-502
and that the speed of ChR-2 would not allow repetitive stimulations faster than~10 Hz. Our physiological data are summarized as follows: 1) We did not find a CM (at the round window) at the 10 Hz frequency of the light stimulation. 2) We failed to see any modulation of acoustically evoked high frequency CM when light was directed into the cochlea via the round window, whereas viable OHCs with ChR-2 were verified histologically. 3) There was no change at the CAP for tone pips of appropriate frequency to the location of light stimulation or of the 900Hz quadratic distortion response.
The interpretation of CM must be made with attention to the phase shifts (due to the traveling wave) among the hair cell voltage generation. Although one cannot be certain, it is unlikely that a true ChR-2 effect occurred but was masked by a shift in the pattern of the OHC phase array changes.
Reasons for the lack of in vivo effect
The expression density of ChR-2 in the genetic model could be responsible by providing too small an OHC membrane current. The effectiveness of a cation channel to control membrane potential will depend on how much conductance can be added to the cell membrane compared to other membrane conductances. In the OHC there is a great deal of potassium conductance allowing for exit of mechanotransduction ions. Qualitatively, however, we did not observe a noticeable difference in tdTomato fluorescence intensity between AAV-ChR-2-tdTomato transduced OHCs versus OHCs that expressed the fusion protein from the ChR-2-tdTomato conditional allele.
In vivo, voltage-gated potassium channels can be activated by a depolarized state of OHCs (42) , although there is debate on the normal polarization state (43, 44) . Thus, OHCs already have a high conductance in the intact cochlea, where OHC membrane potential is known to be low. ChR-2 current will not add much additional depolarization. However, this speculation is tempered by the patch clamp data, wherein isolated, apical, neonatal (p8-10) OHCs did show depolarization by light even when tested at a depolarized 40 mv membrane holding potential. The exact effect of ChR-2 channels will also include a balance between the repolarization by K channels due to reversed potential and depolarization from the nonspecific ChR-2 channel.
We believe that methodological problems related to the slow speed of repetitive activation of ChR-2 are the cause of the failure to observe in vivo effects. The slow speed essentially forces the responses to be direct current (DC) for the high frequency location of the cochlea. In contrast, the 10 Hz speed is more appropriate for the apex, where an interferometry method such as spectral domain optical coherence tomography (that can measure through intact bone of the cochlea) might possibly detect the response. To elaborate, a simple model for the effect of ChR-2 current on in vivo response could be described as follows. From   Fig. 7 , the light-induced cationic current from ChR-2 generated by 0.52 mW/mm 2 light impinging on isolated OHCs, for a holding potential of À70 mV, is~0.2 nA. This current is comparable to the mechanoelectrical transduction (MET) current at low sound stimulus levels. A 40 dB SPL sound stimulus generates~0.225 nA of MET current in a single OHC at 19 kHz characteristic frequency in the guinea pig basal turn (45) , although, the values in mouse are not known. However, there is a key difference. The MET current is an alternating current at the frequency of the sound stimulus, whereas the light-induced cationic current is a DC current. This DC current generates a depolarizing membrane potential in the OHCs when the light is ON (and reverts back upon turning off the light), which thereby temporarily reduces the DC potential driving the cochlear amplifier.
The DC potential driving the cochlear amplifier, (e.g., Ramamoorthy et al. (46) ) is the difference between the endocochlear potential and the OHC resting potential. The endocochlear potential in a mature mouse is 100 mV (47) and the OHC resting potential is À75 mV (48) thus giving a normal value of 175 mV for the DC potential in a mouse. In isolated mouse OHCs, we measured ChR-2-induced peak depolarization of 5 mV and a steady-state depolarization of 1.67 mV for a light intensity of 0.52 mW/mm 2 . It has been shown that, for low light intensities, the ChR-2 response is proportional to light intensity (41) . Therefore, for a light stimulus of 6 mW/mm 2 reaching the OHCs in the mouse hook in our in vivo experiments, the steady-state OHC depolarization is~19 mV. The DC potential driving the cochlear amplifier therefore reduces to 156 mV (i.e., to 89%) during light stimulation in vivo. Computational modeling (46) shows that this reduction in the DC potential is sufficient to cause 10 dB reduction in the peak vibration to low sound stimulus levels (20 dB SPL) at the characteristic frequency. However, as the sound stimulus level increases, the effect of reduced DC potential on the sound-induced vibration gradually diminishes. Our CM and 900 Hz electrical quadratic distortion product measurements at the round window were made at sound levels starting from~20 dB SPL but we did not notice a change with light stimulus (note that although 10 dB reduction with light is expected in the local sound-induced vibration near the characteristic frequency, the effect on CM would be lower as latter is not strictly a local response). It is therefore likely that we were on the verge of the possible detection of light-induced ChR-2 effect on in vivo cochlear response. We expect that it would be possible to experimentally measure these ChR-2 effects by a) availability and use of faster opsins to enable a.c. change in OHC membrane potential, b) improving the strength of opsin current induced by light, and c) development of a more sensitive technique to measure high frequency responses to use lower sound stimulus levels (~0 dB SPL) via the mouse round window.
Future directions for opsin use in the organ of Corti Future genetic models can solve the multiproblems we encountered and bring opsin control of the organ of Corti into practice. This will surely happen more quickly for opsin expression targeted to neurons for potential use in cochlear prosthetics (49, 50) . 1) New channel variants can be faster, more sensitive to light, have higher expression, more stable on current (less desensitization), and be activated by different wavelengths. There are several recent and promising candidates such as ChETA that has very fast kinetics (51) , and ChIEF that has less desensitization; keeping consistent current responses when stimulated with high frequency pulsed light (38) . Additionally, as ChEF and ChIEF have better expression and membrane trafficking in mammalian cells than ChR-2 (17,52), it would be very interesting to express these ChR mutants to OHCs and perhaps observe improved responses both in vivo and in vitro.
2) The recent ChR activated by red light would allow for efficient, trans-otic capsule stimulation in the different cochlear turns, as red light can penetrate through bone, whereas blue light cannot (53).
3) The ChRs described previously are all about exciting (depolarizing) cells. It will be helpful to engineer and express opsins that can hyperpolarize or silence cells. The examples of these are halorhodopsin, a light-sensitive chloride channel, and archaerhodopsin-3, a light-sensitive proton pump (10, 29, 54) . The hyperpolarizing opsins may prove to be more capable in controlling membrane potential as the current is anionic. Other variants such as the modified ChR cation channel to pass chloride (53) could provide a way to cause prestin action via a mechanism independent of membrane potential. For example, locally increasing chloride at the membrane and near prestin might cause a bias of prestin to the chloride induced increased area state. In general, any change in the normal homeostatic electromechanical environment would tend to shift away from the optimal state of the cell and thus reduce cochlear amplification gain. Cochlear mechanics experiments on amplification, wave propagation, and emission distortion can easily be built upon a spatially controllable cochlear gain. 4) Safe and efficient methods might be found to transfer and express ChRs in OHCs for clinical use. This could be made through viral transfer as we did in the current study, or plasmid or transplantation of ChR-2 expression OHCs to the cochlea. The clinical application of optogenetic control of cochlear amplification is certainly possible. To our knowledge, despite the problems encountered in this first study of opsins for the organ of the Corti, many promising avenues remain to be explored to control sensory and supporting cell physiology and unlock the door to a better understanding of cochlear functions.
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